艾力斯

688578 SSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

40.6B ($5.9B)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

3.6B

Net Income

1.4B

Gross Margin

N/A

Op. Margin

46.0%

Net Margin

40.2%

ROE

27.1%

ROA

24.2%

D/E

0.12

Dividend Yield

N/A

EPS

3.18

Current Ratio

6.96

Price History

Company Info

Industry	C27医药制造业
Market Segment	STAR Market
Currency	CNY
Fiscal Year	2024

Business Overview

Shanghai Allist Pharmaceuticals Co., Ltd., a pharmaceutical company, engages in the research and development of tumor-targeted drugs in China. Its lead product is vometinib mesylate tablet for the treatment of patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer (NSCLC), as well as for treating adult patients with locally advanced or metastatic NSCLC. The company was founded in 2004 and is based in Shanghai, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 艾力斯

Ticker	688578
Exchange	SSE
Sector	证监会行业分类
Industry	C27医药制造业